Myovant Sciences Ltd. (MYOV)
NYSE: MYOV
· Real-Time Price · USD
26.98
-0.01 (-0.04%)
At close: Mar 09, 2023, 10:01 PM
Myovant Sciences Ratios and Metrics
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
PE Ratio | -11.33 | -9.47 | -13.96 | -5.3 | -5.73 | -24 | -8.46 | -5.76 | -8.42 | -4.7 | -14.01 |
PEG Ratio | -0.44 | -0.08 | 0.21 | 0.72 | -0.03 | 0.37 | 0.34 | -0.67 | -0.9 | -0.05 | 0.28 |
PS Ratio | 26.05 | 16.48 | 10.18 | 21.84 | 26.73 | 26.60 | 50.81 | 76.13 | 1.8K | n/a | 55.24 |
PB Ratio | -4.68 | -3.37 | -2.45 | -2.66 | -3.37 | -5.41 | -5.22 | -5.29 | -9.19 | -6.31 | -13.68 |
P/FCF Ratio | -25.32 | 196.22 | -15.59 | -12.53 | -15.78 | 57.19 | -18.44 | -20 | 4.34 | -25.64 | -29.63 |
P/OCF Ratio | -25.38 | 189.47 | -15.6 | -12.56 | -15.84 | 56.63 | -18.44 | -20.15 | 4.33 | -25.95 | -29.71 |
OCF/S Ratio | -1.03 | 0.09 | -0.65 | -1.74 | -1.69 | 0.47 | -2.76 | -3.78 | 416.35 | n/a | -1.86 |
Debt / Equity Ratio | -0.66 | -0.71 | -0.76 | -0.78 | -0.85 | -0.96 | -0.92 | -1.04 | -1.2 | -1.33 | -1.53 |
Quick Ratio | 1.45 | 1.74 | 1.79 | 1.92 | 2.11 | 2.42 | 2.27 | 2.50 | 2.99 | 1.75 | 2.07 |
Current Ratio | 1.57 | 1.83 | 1.89 | 1.95 | 2.14 | 2.44 | 2.28 | 2.50 | 2.99 | 1.75 | 2.07 |
Asset Turnover | 0.25 | 0.22 | 0.25 | 0.11 | 0.09 | 0.11 | 0.06 | 0.03 | 0.00 | n/a | 0.26 |
Interest Coverage | -8.48 | -7 | -2.23 | -14.87 | -17.17 | -5.25 | -16.35 | -22.03 | -30.02 | -33.97 | -15.42 |
Return on Equity | 0.10 | 0.09 | 0.04 | 0.13 | 0.15 | 0.06 | 0.15 | 0.23 | 0.27 | 0.34 | 0.24 |
Return on Assets | -0.14 | -0.09 | -0.05 | -0.11 | -0.1 | -0.03 | -0.08 | -0.11 | -0.1 | -0.49 | -0.26 |
Return on Invested Capital | -0.33 | -0.17 | -0.06 | -0.2 | -0.18 | -0.04 | -0.14 | -0.17 | -0.15 | -1.01 | -0.45 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.66 | 0.74 | 0.80 | 0.69 | 0.70 | 0.86 | 0.85 | 0.92 | 1.00 | n/a | 1.00 |
Net Profit Margin | -0.57 | -0.44 | -0.18 | -1.03 | -1.17 | -0.28 | -1.5 | -3.31 | -53.55 | n/a | -0.99 |
Pretax Profit Margin | -0.56 | -0.36 | -0.11 | -0.96 | -1.16 | -0.28 | -1.48 | -3.27 | -54.39 | n/a | -0.97 |
Operating Profit Margin | -0.52 | -0.32 | -0.08 | -0.9 | -1.1 | -0.24 | -1.4 | -3.13 | -56.79 | n/a | -1.01 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.49 | -0.3 | -0.07 | -0.89 | -1.08 | -0.22 | -1.38 | -3.1 | -56.79 | n/a | -1.01 |